P L Harris
The incidence of abdominal aortic aneurysms in the British Isles as in other Western countries has risen dramatically during the second half of this century. ' Not only has there been a steady expansion in the population of elderly men, who are most at risk,2 but there is also evidence of a true increase in age specific prevalence,' which may be related to progressive transmission of a familial predisposition to the disease. 4 These trends seem set to continue.
Against this background it is a matter for serious concern that the interventions ofthe medical profession have not had more impact on the very high mortality associated with this condition. Lack of an effective treatment is not the problem. -In the best centres elective surgical repair of abdominal aortic aneurysms carries an operative risk of under 5% and a subsequent longevity and quality of life which compares very favourably with normal expectations. 5 The persistently high mortality is accounted for by the fact that a substantial majority of aneurysms remain asymptomatic until the moment of rupture, when it is usually too late for effective intervention. Of patients who reach hospital alive, between 50% and 70% can be saved by emergency surgery, but we know that many more die with a suddenness which denies them the benefit of hospital treatment. 6 Secondly, for mass screening to be realistic the prevalence of the disease among those screened must be high, and it is therefore important to be able to define a population at risk. Abdominal aortic aneurysm is predominantly a disease of men past middle age and is uncommon in women except for the very elderly.'5 The greatest relative importance of the disease is in men aged 70-74, in whom it accounts for 1-72% of all deaths. '6 In Birmingham screening of 2669 asymptomatic men between the ages of 65 and 75 disclosed 219 (8-2%) with an aortic diameter greater than 29 mm and 70 (2-6%) with an aortic diameter in excess of 40mm. 9 Results from other studies in the United Kingdom have been broadly similar.' 1'2 Their collective evidence suggests that a programme to screen all apparently healthy men once, on or about their 65th birthday, will detect the majority of aneurysms. Other especially high risk groups are male siblings of patients with aneurysms, a quarter of whom also have the disease,'7 18 and patients who present other manifestations of chronic arterial disease-for example, those with intermittent claudication, in whom the incidence is 10-15%.'9 They require special provision for screening irrespective of any plans to screen apparently healthy people.
An important factor which can seriously undermine the value of any screening programme is low patient compliance. Experience from studies in the United Kingdom shows that response rates vary from about 50% in inner city areas to over 85% in middle class suburbs. Given the uncertain aetiology of the disease and its essentially occult nature, neither attempts at prevention nor the introduction ofinnovative methods oftreatment can be expected to have much impact on the number of deaths from this cause. The essential requirement is to detect a higher proportion of lesions before rupture when most are asymptomatic, and from the evidence presented here it is apparent that this objective is both feasible and affordable. If it is accepted that the currently high mortality from abdominal aortic aneurysm must be reduced, then it follows that there is a need for a national screening programme. Asking a clinical scientist when he or she last read the Declaration of Helsinki' is rather like asking a seasoned airline traveller when he or she last listened to the safety announcement. The declaration sets out ethical principles which no one seriously disputes and on which other authoritative statements'-' are essentially commentary. But the Declaration of Helsinki is sometimes more difficult to put into practice than to replicate on paper. Two of its principles, for example, mark out an area of possible moral conflict: "research involving human subjects must conform to generally accepted scientific standards," and "concern for the interests of the subject must always prevail over the interest of science and society." AIDS research highlights this possible conflict but also suggests new ways of resolving it. The scientific gold standard today is the randomised clinical trial. Scientists have found no more effective way to reduce bias, control variables, and establish priorities among the available options. Alternatives which have been suggested-for example, "prospective studies without randomization, but with the evaluation of patients by uninvolved third parties," or "prospective matched-pair analysis in which patients are treated in a manner consistent with their physician's views"'7-do not remove bias sufficiently. Many patients become subjects of research from which they receive no direct benefit. The research may be non-therapeutic or, as a result of randomisation in a therapeutic clinical trial, the patient may be given a treatment which turns out to be ineffective or not given what turns out to be an effective treatment.
A subject's failure to benefit directly need not mean that concern for the interest of science and society has prevailed over concern for that of the subject. Doctors have a duty to avoid harm to their patients and to serve their best interest. But 
